In summary, our data indicate that Ki-67, S-100, PCNA, and P53 expression levels in glioma are associated with local/nonlocal recurrence, and the MGMT expression level is associated with paraventricular/nonparaventricular recurrence. The gene discussed is S100B; the disease is central nervous system cancer.